Pages that link to "Q40714205"
Jump to navigation
Jump to search
The following pages link to Is migraine prophylactic activity caused by 5-HT2B or 5-HT2C receptor blockade? (Q40714205):
Displaying 32 items.
- Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy (Q24321991) (← links)
- 5-HT2 receptor subtypes: a family re-united? (Q28303964) (← links)
- Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system (Q28583455) (← links)
- Strategies for the synthesis of novel indole alkaloid-based screening libraries for drug discovery (Q31156013) (← links)
- A Divergent SAR Study Allows Optimization of a Potent 5-HT2c Inhibitor to a Promising Antimalarial Scaffold (Q33630572) (← links)
- Primary headache disorders and neuro-ophthalmologic manifestations (Q33702135) (← links)
- The pharmacology of headache (Q33952000) (← links)
- Serotonin Receptors – From Molecular Biology to Clinical Applications (Q34143560) (← links)
- Neuroleptics in headache (Q34412065) (← links)
- Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine? (Q34590949) (← links)
- Serotonin and migraine: biology and clinical implications (Q34655338) (← links)
- Migraine: preventive treatment (Q34852689) (← links)
- Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine (Q35884702) (← links)
- Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers (Q35936959) (← links)
- Migraine: current concepts and emerging therapies (Q36229186) (← links)
- Hypoxia facilitates neurogenic dural plasma protein extravasation in mice: a novel animal model for migraine pathophysiology (Q36353546) (← links)
- Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications. (Q36912182) (← links)
- Current and prospective pharmacological targets in relation to antimigraine action (Q37216396) (← links)
- The biological basis of headache (Q37849764) (← links)
- 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives (Q40571185) (← links)
- Headache induced by serotonergic agonists--a key to the interpretation of migraine pathogenesis? (Q41364582) (← links)
- How do the currently used prophylactic agents work in migraine? (Q41460269) (← links)
- In vivo modulation of vagal-identified dorsal medullary neurones by activation of different 5-Hydroxytryptamine(2) receptors in rats (Q41831449) (← links)
- Investigations into migraine pathogenesis: time course for effects of m-CPP, BW723C86 or glyceryl trinitrate on appearance of Fos-like immunoreactivity in rat trigeminal nucleus caudalis (TNC). (Q43572323) (← links)
- Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation (Q44326286) (← links)
- Treatment of refractory chronic daily headache with the atypical antipsychotic ziprasidone--a case series (Q46702831) (← links)
- Prophylactic therapy for migraine (Q47311786) (← links)
- The induction of pain: an integrative review (Q48284194) (← links)
- Serotonin in migraine: theories, animal models and emerging therapies. (Q48289121) (← links)
- Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action. (Q53407201) (← links)
- Characterisation of 5-HT2 receptor subtypes in the Suncus murinus intestine (Q73165434) (← links)
- Bradykinin and phorbol ester but not 5-HT2B receptor activation stimulate phospholipase D activity in the rat stomach fundus (Q77951113) (← links)